tirofiban has been researched along with Blood Loss, Postoperative in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dager, WE; Walker, EA | 1 |
| Jiang, L; Lin, L; Parsons, MW; Wu, Y; Yang, J; Yin, C | 1 |
| Chen, TW; Huang, H; Jiang, L; Liu, KQ; Sang, HF; Si, XL; Xia, WQ; Yin, CG | 1 |
| Liu, XH; Qu, Y; Shen, H; Xia, JG | 1 |
| Boschetti, E; D'Urbano, M; De Servi, S; Klugmann, S; La Vecchia, C; Lazzari, L; Martina, P; Morici, N; Musumeci, G; Rossini, R; Savonitto, S; Senni, M | 1 |
| Carteaux, JP; Durand, M; Hacquard, M; Lecompte, T | 1 |
| Bizzarri, F; Frati, G | 1 |
| Ioannidis, JP; Karvouni, E; Katritsis, DG | 1 |
| Belcher, PR; Menys, VC; Muriithi, EW | 1 |
| Shanmugam, G | 1 |
| Boeken, U; Feindt, P; Gams, E; Kurt, M; Litmathe, J | 1 |
| Despotis, GJ; Moon, MR; Skubas, NJ; Vlasnic, JJ | 1 |
| Collard, CD; Lewis, W | 1 |
| Bizzarri, F; Davoli, G; Frati, G; Lucidi, M; Muzzi, L; Neri, E; Scolletta, S; Toscano, T; Tucci, E | 1 |
| Bertrand, M; Cohen, DJ; Cohen, EA; Cohen, M; DiBattiste, PM; Grines, CL; Herrmann, HC; Moliterno, DJ; Moses, JW; Neumann, FJ; Powers, ER; Stone, GW; Topol, EJ; Wolski, K | 1 |
2 review(s) available for tirofiban and Blood Loss, Postoperative
| Article | Year |
|---|---|
Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Atherectomy, Coronary; Coronary Disease; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Hemorrhage; Randomized Controlled Trials as Topic; Risk; Stents; Survival Analysis; Tirofiban; Tyrosine | 2003 |
Tirofiban and emergency coronary surgery.
Topics: Acute Disease; Administration, Oral; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Emergencies; Humans; Infusions, Intravenous; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Hemorrhage; Thrombocytopenia; Tirofiban; Tyrosine | 2005 |
2 trial(s) available for tirofiban and Blood Loss, Postoperative
| Article | Year |
|---|---|
Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
Topics: Aged; Aspirin; China; Clopidogrel; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prospective Studies; Risk Factors; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2013 |
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial.
Topics: Abciximab; Acute Disease; Aged; Antibodies, Monoclonal; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Disease-Free Survival; Double-Blind Method; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Severity of Illness Index; Stents; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine | 2002 |
11 other study(ies) available for tirofiban and Blood Loss, Postoperative
| Article | Year |
|---|---|
Bridging with Tirofiban during Oral Antiplatelet Interruption: A Single-Center Case Series Analysis Including Patients on Hemodialysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Intraoperative Care; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Renal Dialysis; Retrospective Studies; Stents; Tirofiban; Treatment Outcome; Tyrosine | 2017 |
Endovascular Thrombectomy.
Topics: Aged; Aged, 80 and over; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Stroke; Thrombectomy; Tirofiban | 2018 |
Mechanical Thrombectomy Using Solitaire in Acute Ischemic Stroke Patients with Vertebrobasilar Occlusion: A Prospective Observational Study.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Multivariate Analysis; Postoperative Hemorrhage; Prognosis; Prospective Studies; Stroke; Thrombectomy; Time-to-Treatment; Tirofiban; Tomography, X-Ray Computed; Vertebrobasilar Insufficiency | 2019 |
Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: Analysis of 314 patients.
Topics: Ambulatory Care; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Stenosis; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Hemorrhage; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Surgical Procedures, Operative; Tirofiban; Tyrosine | 2016 |
Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade.
Topics: Anticoagulants; Cardiopulmonary Bypass; Drug Therapy, Combination; Factor VIIa; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Postoperative Hemorrhage; Reoperation; Thrombocytopenia; Tirofiban; Tyrosine | 2008 |
Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting: is there a paradox?
Topics: Acute Coronary Syndrome; Acute Disease; Cardiopulmonary Bypass; Coronary Artery Bypass, Off-Pump; Humans; Metabolic Clearance Rate; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Premedication; Risk Factors; Thrombocytopenia; Tirofiban; Tyrosine | 2009 |
Preoperative platelet inhibition and bleeding after cardiopulmonary bypass.
Topics: Cardiopulmonary Bypass; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Postoperative Hemorrhage; Preoperative Care; Time Factors; Tirofiban; Tyrosine | 2003 |
CABG-procedures in patients with pretreatment with the GPIIb/IIIa-receptor antagonist tirofiban (Aggrastat): modification of perioperative management?
Topics: Antifibrinolytic Agents; Aprotinin; Coronary Artery Bypass; Fibrinolytic Agents; Hemostatics; Humans; Postoperative Hemorrhage; Preoperative Care; Retrospective Studies; Tirofiban; Tranexamic Acid; Tyrosine | 2008 |
Preoperative use of enoxaparin and tirofiban: possible association with increased bleeding postbypass.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Coronary Artery Bypass; Enoxaparin; Humans; Male; Postoperative Hemorrhage; Tirofiban; Tyrosine | 1999 |
Does perioperative antithrombotic therapy increase the likelihood of a postoperative coagulopathy after cardiac surgery?
Topics: Cardiac Surgical Procedures; Drug Administration Schedule; Enoxaparin; Fibrinolytic Agents; Humans; Intraoperative Period; Postoperative Hemorrhage; Tirofiban; Tyrosine | 2000 |
Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
Topics: Blood Transfusion; Case-Control Studies; Coronary Artery Bypass; Emergencies; Female; Heparin; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Postoperative Hemorrhage; Time Factors; Tirofiban; Tyrosine | 2001 |